- Home
- ANEB vs ORGN Comparison
ANEB vs ORGN Comparison
Compare ANEB & ORGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANEB
- ORGN
- Stock Information
- Founded
- ANEB 2020
- ORGN 2008
- Country
- ANEB United States
- ORGN United States
- Employees
- ANEB N/A
- ORGN N/A
- Industry
- ANEB Biotechnology: Pharmaceutical Preparations
- ORGN Major Chemicals
- Sector
- ANEB Health Care
- ORGN Industrials
- Exchange
- ANEB Nasdaq
- ORGN Nasdaq
- Market Cap
- ANEB 111.8M
- ORGN 109.4M
- IPO Year
- ANEB 2021
- ORGN N/A
- Fundamental
- Price
- ANEB $2.27
- ORGN $0.49
- Analyst Decision
- ANEB Buy
- ORGN
- Analyst Count
- ANEB 2
- ORGN 0
- Target Price
- ANEB $8.00
- ORGN N/A
- AVG Volume (30 Days)
- ANEB 17.9K
- ORGN 1.1M
- Earning Date
- ANEB 11-13-2025
- ORGN 11-13-2025
- Dividend Yield
- ANEB N/A
- ORGN N/A
- EPS Growth
- ANEB N/A
- ORGN N/A
- EPS
- ANEB N/A
- ORGN N/A
- Revenue
- ANEB N/A
- ORGN $25,122,000.00
- Revenue This Year
- ANEB N/A
- ORGN $49.18
- Revenue Next Year
- ANEB N/A
- ORGN $144.81
- P/E Ratio
- ANEB N/A
- ORGN N/A
- Revenue Growth
- ANEB N/A
- ORGN N/A
- 52 Week Low
- ANEB $0.80
- ORGN $0.40
- 52 Week High
- ANEB $3.42
- ORGN $1.36
- Technical
- Relative Strength Index (RSI)
- ANEB 33.07
- ORGN 40.08
- Support Level
- ANEB $2.32
- ORGN $0.46
- Resistance Level
- ANEB $2.39
- ORGN $0.75
- Average True Range (ATR)
- ANEB 0.09
- ORGN 0.04
- MACD
- ANEB -0.04
- ORGN -0.01
- Stochastic Oscillator
- ANEB 0.00
- ORGN 15.50
About ANEB Anebulo Pharmaceuticals Inc.
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing treatments for cannabinoid overdose and substance addiction. Its principal product candidate, ANEB-001 (Selonabant), is designed to rapidly counteract the negative effects of cannabis toxicity, including unintentional cannabis poisoning and acute cannabinoid intoxication. The company is focusing on addressing the unmet medical needs in the treatment of cannabinoid toxicity through various therapies. Anebulo Pharmaceuticals operates in one segment, exclusively in the United States.
About ORGN Origin Materials Inc.
Origin Materials Inc is a carbon-negative materials company. The platform turns the carbon found in biomass into useful materials, while eliminating the need for fossil resources and capturing carbon in the process. Its products include, PET circular caps and closures, Para-xylene, carbon black, Levulinic acid among others by using materials like food and beverage packaging, clothing, textiles, plastics, car parts, carpeting, tires, adhesives, soil amendments, and fuels.